Manifestações psiquiátricas na reumatologia

Silvia Poliana Guedes Alcoforado Costa; Camila Farias Araujo; Taís Simplício Ramos; Philip Azevedo Costa Urquiza; Amaury  Cantilino

doi:10.25118/2763-9037.2022.v12.279

Autores

Silvia Poliana Guedes Alcoforado Costa Médica residente no Hospital das Clínicas da Universidade Federal de Pernambuco https://orcid.org/0000-0002-6478-3847
Camila Farias Araujo Médica residente no Hospital das Clínicas da Universidade Federal de Pernambuco https://orcid.org/0000-0002-8359-3846
Taís Simplício Ramos Graduanda do curso de Medicina da Universidade Federal de Pernambuco (UFPE) https://orcid.org/0000-0002-2197-3712
Philip Azevedo Costa Urquiza Médico Residente do Programa de Psiquiatria do Hospital das Clínicas de Pernambuco https://orcid.org/0000-0002-9790-4502
Amaury Cantilino Universidade Federal de Pernambuco https://orcid.org/0000-0002-4382-1218

DOI:

https://doi.org/10.25118/2763-9037.2022.v12.279

Palavras-chave:

Artrite Reumatoide, Lúpus Eritematoso Sistêmico, Transtornos Mentais

Resumo

A presente revisão de literatura investigou sintomas relacionados à Artrite Reumatoide e ao Lúpus Eritematoso Sistêmico. Entendemos que um novo paradigma deve ser estabelecido na psiquiatria, ao considerar que a correlação das doenças reumatológicas com sintomas psiquiátricos deve ser valorizada e deve servir de auxílio para o aprimoramento de propostas terapêuticas e diagnósticas na saúde mental. Assim, buscamos traçar indícios de protótipos de condições psiquiátricas mais caracteristicamente associadas às condições reumatológicas citadas. Sintomas relacionados a transtornos de humor, principalmente depressão, foram bastante correlacionados à maior incidência e morbidade na Artrite Reumatoide. Os déficits cognitivos, especialmente moderados, são os sintomas neuropsiquiátricos mais prevalentes no Lúpus Eritematoso Sistêmico. O tratamento da doença reumatológica de base se mostra primordial para que haja melhora da condição psiquiátrica associada, seja por influência direta ou indireta. Quanto ao Lúpus, as atuais estratégias terapêuticas são, em grande parte, empíricas, realizadas através dos mecanismos imunopatogênicos conhecidos e do que foi observado a partir do tratamento de manifestações graves em outros órgãos. Quanto à Artrite Reumatóiode, o tratamento farmacológico específico da condição psiquiátrica se faz essencial de acordo com a demanda individual de cada paciente, valorizando sempre a intersubjetividade e os aspectos psicossomáticos apresentados.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Isaac ML, Larson EB. Medical conditions with neuropsychiatric manifestations. Med Clin North Am [Internet]. 2014;98(5):1193-208. https://doi.org/10.1016/j.mcna.2014.06.012 - PMid:25134879

Senna ER, Barros AL, Silva OE, Costa SE, Pereira LV, Ciconelli, RM, Ferraz MB. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. Journal of Rheumathology, v. 31, n. 3, 2004. p. 594-597. https://pubmed.ncbi.nlm.nih.gov/14994410/

Asano AMJ, Coriolano MGWS, Anano BJ, Lins OG. Comorbidades psiquiátricas em pacientes com lúpus eritematoso sistêmico: uma revisão sistemática dos últimos 10 anos. Rev. Bras. Reumatol. São Paulo , v. 53, n. 5, p. 431-437, Oct. 2013. https://doi.org/10.1590/S0482-50042013000500010

Joaquim AF, Appenzeller S. Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev [Internet]. 2015;14(12):1116-22. https://doi.org/10.1016/j.autrev.2015.07.015 - PMid:26238502

Wang Q, Yang C, Gelernter J, Zhao H. Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS. Hum Genet [Internet]. 2015 Nov 4 [cited 2019 Aug 25];134(11-12):1195-209.

https://doi.org/10.1007/s00439-015-1596-8 - PMid:26340901 PMCid:PMC4630076

Hassan AA, Nasr MH, Mohamed AL, Kamal AM, Elmoghazy AD. Psychological affection in rheumatoid arthritis patients in relation to disease activity. Medicine (Baltimore) [Internet]. 2019 May [cited 2019 Jul 22];98(19):e15373. https://doi.org/10.1097/MD.0000000000015373 - PMid:31083165 PMCid:PMC6531278

Kim H-A, Jeon J-Y, Koh B-R, Park S-B, Suh C-H. Salivary cortisol levels, but not salivary α-amylase levels, are elevated in patients with rheumatoid arthritis irrespective of depression. Int J Rheum Dis [Internet]. 2016 Feb [cited 2019 Jul 22];19(2):172-7.

https://doi.org/10.1111/1756-185X.12224 - PMid:24237602

Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, et al. Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken) [Internet]. 2018 Jul [cited 2019 Aug 20];70(7):970-8. https://doi.org/10.1002/acr.23539

PMid:29438604 - PMCid:PMC6033023

Jump RL, Fifield J, Tennen H, Reisine S, Giuliano AJ. History of affective disorder and the experience of fatigue in rheumatoid arthritis. Arthritis Care Res (Hoboken) [Internet]. 2004 Apr 15 [cited 2019 Aug 20];51(2):239-45. https://doi.org/10.1002/art.20243 - PMid:15077266

Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S, Galloway J. The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register. Rheumatol (United Kingdom) [Internet]. 2018 May 1 [cited 2019 Jul 22];57(5):835-43. https://doi.org/10.1093/rheumatology/kex528 - PMid:29447376

Gjevre JA, Taylor-Gjevre RM, Nair B V., Lim HJ. Do Sleepy Rheumatoid Arthritis Patients Have A Sleep Disorder? Musculoskeletal Care [Internet]. 2012 Dec [cited 2019 Aug 20];10(4):187-95. https://doi.org/10.1002/msc.1016 - PMid:22577060

Shin SY, Katz P, Wallhagen M, Julian L. Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken) [Internet]. 2012 Aug [cited 2019 Aug 20];64(8):n/a-n/a.

https://doi.org/10.1002/acr.21683 - PMid:22505279 PMCid:PMC3744877

Kitamura E, Kondo Y, Kanazawa N, Akutsu T, Nishiyama K, Iizuka T. Autoimmune Encephalitis as an Extra-articular Manifestation of Rheumatoid Arthritis. Intern Med [Internet]. 2019 Apr 1 [cited 2019 Jul 22];58(7):1007-9. https://doi.org/10.2169/internalmedicine.1846-18 - PMid:30449780 - PMCid:PMC6478993

Sul A. Artigo Revisão artrite reumatoide inicial - conceitos. 2010;56(2):227-9. https://doi.org/10.1590/S0104-42302010000200024 - PMid:20499000

Mota LMH, Cruz BA, Brenola CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, Freitas MVC, Silva NA, Louzada-Junior P, Giorgio RDN, Lima RAC, Kairalla RA, Kawassaki AM, Bernardo WM, Castelar Pinheiro GRC. Guidelines for the diagnosis of rheumatoid arthritis. Rev Bras Reumatol [Internet]. 2013 [cited 2019 Sep 8];53(2):141-57. https://doi.org/10.1016/S2255-5021(13)70019-1

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum, NS, Burmester, GR, Bykerk, VP, Cohen, MD, Combe, B, Costenbader, KH, Dougados, M, Emery, P, Ferraccioli, G, Hazes, JMW, Hobbs, K, Huizinga, TWJ, Kavanaugh, A, Kay, J, Kvien, TK, Laing, T, Mease, P, Ménard, HA, Moreland, LW, Naden, RL, Pincus, T, Smolen, JS, Stanislawska-Biernat, E, Symmons, D, Tak, PP, Upchurch, KS, Vencovský, J, Wolfe, F, Hawker, G. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum [Internet]. 2010 Sep [cited 2019 Sep 8];62(9):2569-81.

https://doi.org/10.1002/art.27584 - PMid:20872595

McGregor K, Bernatsky S, Colmegna I, Hudson M, Pastinen T, Labbe A, Greenwood CMT. An evaluation of methods correcting for cell-type heterogeneity in DNA methylation studies. Genome Biol [Internet]. 2016 May 3 [cited 2019 Jul 22];17(1):84.

https://doi.org/10.1186/s13059-016-0935-y - PMid:27142380 PMCid:PMC4855979

Jiang HK, Chang DM. Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: Five case reports. Clin Rheumatol. 1999;18(4):339-45. https://doi.org/10.1007/s100670050114 - PMid:10468178

Alessi H, Dutra LA, Braga-Neto P, Pedroso JL, Toso FF, Kayser C, Barsottini OGP. Lúpus neuropsiquiátrico na prática clínica. Arq Neuropsiquiatr. 2016 Dec 1;74(12):1021-30. https://doi.org/10.1590/0004-282x20160150 - PMid:27992002

Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, Ceruti S, Trotta F. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. Vol. 74, Journal of Autoimmunity. Academic Press; 2016. p. 41-72.

https://doi.org/10.1016/j.jaut.2016.06.013 - PMid:27427403

Vargas JV, Vaz CJ. Evaluation of central nervous system involvement in SLE patients. Screening psychiatric manifestations - a systematic review. Acta Reumatol Port. 2014;39(3):208-17.

Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: Pathogenesis and biomarkers. Vol. 10, Nature Reviews Neurology. Nature Publishing Group; 2014. p. 579-96.

https://doi.org/10.1038/nrneurol.2014.148 - PMid:25201240

Hajduk A, Nowicka-Sauer K, Smoleńska Z, Czuszyńska Z, Zdrojewski Z. Prevalence and correlates of suicidal thoughts in patients with neuropsychiatric lupus. Lupus. 2016;25(2):185-92.

https://doi.org/10.1177/0961203315603136 - PMid:26359173

Cojocaru DC, Costin M, Bădeanu LE, Negru RD, Aursulesei V. Depression: a Fellow Traveler With Systemic Lupus Erythematosus. Rev Med Chir Soc Med Nat Iasi. 2015;119(4):974‐981.

Tang KT, Hsieh CW, Hsieh TY, Lan JL, Chen YH, Chen DY. Suicide Attempts in Patients With Systemic Lupus Erythematosus: A Single-Center Experience and Literature Review. Psychosomatics [Internet]. 2015;56(2):190-5. Available from:

https://doi.org/10.1016/j.psym.2014.05.020 - PMid:25627312

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler E, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2019;71(2):281-9. https://doi.org/10.1002/art.40764 - PMid:30375754 - PMCid:PMC6353684

Jafri K, Patterson SL, Lanata C. Central Nervous System Manifestations of Systemic Lupus Erythematosus. Vol. 43, Rheumatic Disease Clinics of North America. W.B. Saunders; 2017. p. 531-45. https://doi.org/10.1016/j.rdc.2017.06.003 - PMid:29061240

Hanly JG. Diagnosis and management of neuropsychiatric SLE. Vol. 10, Nature Reviews Rheumatology. Nature Publishing Group; 2014. p. 338-47. https://doi.org/10.1038/nrrheum.2014.15 - PMid:24514913

Kivity S, Baker B, Arango MT, Chapman J, Shoenfeld Y. Pharmacologic management of neuropsychiatric lupus. Vol. 9, Expert Review of Clinical Pharmacology. Taylor and Francis Ltd; 2016. p. 103-8. https://doi.org/10.1586/17512433.2016.1111137 - PMid:26559084

Kamen DL, Zollars ES. Corticosteroids in Lupus Nephritis and Central Nervous System Lupus. Rheum Dis Clin North Am [Internet]. 2016;42(1):63-73. Available from: https://doi.org/10.1016/j.rdc.2015.08.008 - PMid:26611551

Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs. 2016;76(4):459-83. https://doi.org/10.1007/s40265-015-0534-3 - PMid:26809245 - PMCid:PMC4791452